⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Pomerantz LLP Advises Investors of Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
businesswire.com
SPRY
Pomerantz LLP Advises Investors of Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
Kaplan Fox Notifies ARS Pharmaceuticals Inc. (SPRY) Investors of an Upcoming Lead Plaintiff Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Pomerantz LLP Advises Investors of Class Action Filing Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
ARS PHARMACEUTICALS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm
globenewswire.com
SPRY
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
SPRY Deadline Alert: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026
globenewswire.com
SPRY